实用医学杂志 ›› 2020, Vol. 36 ›› Issue (21): 2995-3000.doi: 10.3969/j.issn.1006⁃5725.2020.21.022

• 调查研究 • 上一篇    下一篇

DCAMKL⁃1和p53对结直肠癌患者预后的影响

吴雪芳,李霜,杨迎春,涂贵兰,龙训,龙艳丽,陈祎,易韦   

  1. 贵州省人民医院病理科(贵阳550002)
  • 出版日期:2020-11-10 发布日期:2020-11-30
  • 通讯作者: 易韦E⁃mail:yiwei6252@sina.com
  • 基金资助:
    贵州省科学技术基金资助项目(编号:黔科合基础[2019]1193号)

Effect of DCAMKL⁃1 and p53 on prognosis of colorectal cancer patients

WU Xuefang,LI Shuang,YANG Yingchun,TU Guilan,LONG Xun,LONG Yanli,CHEN Yi,YI Wei.#br#   

  1. Department of Pathology,Guizhou Provincial People′ s Hospital,Guiyang 550002,China
  • Online:2020-11-10 Published:2020-11-30
  • Contact: YI Wei E⁃mail:yiwei6252@sina.com

摘要:

目的 评估DCAMKL⁃1 和p53 蛋白在结直肠癌中的表达,分析两者与结直肠癌患者临床病理特征的关系及对预后的影响。方法 应用免疫组织化学法检测126例结直肠癌及癌旁正常黏膜组织中DCAMKL⁃1 和p53 蛋白的表达,分析其在结直肠癌中表达的意义及与患者临床病理特征、预后的关系。结果 结直肠癌DCAMKL⁃1 阳性率为71.4%(90/126)明显高于癌旁正常黏膜(P < 0.05);DCAMKL⁃1 的表达与年龄、性别、肿瘤分化程度、临床分期、淋巴结转移无关(P>0.05)。结直肠癌和癌旁正常肠黏膜p53阴性、弱阳性、弥漫强阳性表达率分别为25.4%(32/126)、14.3%(18/126)、60.3%(76/126)和92.1%(116/126)、7.9%(10/126)、0(0/126),结直肠癌p53 弥漫强阳性表达率60.3%(76/126)明显高于癌旁正常黏膜(P < 0.05)。p53 与临床分期及淋巴结转移有关(χ2 = 3.925、7.292,P<0.05),p53 阴性和弥漫强阳性表达时肿瘤更易发生淋巴结转移(P<0.05)。多因素生存分析显示临床分期是影响结直肠癌患者预后的独立危险因素(P < 0.05)。结论 DCAMKL⁃1、p53与结直肠癌的发生密切相关,p53与结直肠癌的临床分期和淋巴结转移有关,且临床分期是影响患者预后的独立危险因素

关键词: 结直肠癌, DCAMKL?1, p53, 免疫组织化学

Abstract:

Objective To investigate the correlation of DCAMKL⁃1 and p53 expression with pathologicalcharacteristics of colorectal carcinoma(CRC)and patients′ prognosis. Methods DCAMKL⁃1 and p53 expressionin 126 cases CRCs and ANM. The correlations of their expression with patients′ pathological characteristics andprognosis were evaluated based on Spearman correlation analysis and survival analysis. Results In CRCs,the pos⁃itive rate of DCAMKL⁃1 was 71.4%(90/126),which was significantly higher than that of ANMs(P < 0.05).There was no correlation between DCAMKL⁃1 expression and patients′ age,gender,clinical stage,lymph nodemetastases(P > 0.05). The distributions of CRCs and ANMs were 25.4%(32/126),14.3%(18/126),60.3%(76/126)and 92.1%(116/126),7.9%(10/126),0(0/126)in the p53⁃no,mild and strong expression groups,respectively. In CRCs,the strong positive rate of p53 was 60.3%(76/126),which was significantly higher thanthat of ANMs(P <0.05). The expression of p53 was associated with clinical stage(χ2 = 3.925,P<0.05)andlymph node metastasis(χ2 = 7.292,P<0.05). The CRCs with p53⁃no and p53 strong expression are prone tometastasize(P<0.05). Multivariate analysis revealed that clinical stage was independent prognostic factors of CRCpatients(P < 0.05). Conclusions DCAMKL⁃1 and p53 are closely related to the occurrence of CRC. p53 isrelated to the clinical stage and lymph node metastasis. Clinical stageis independent prognostic indicator of CRC.


Key words: colorectal carcinoma, DCAMKL?1, p53, immunohistochemistry